- Home
- JZXN vs ICU Comparison
JZXN vs ICU Comparison
Compare JZXN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JZXN | ICU |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 15.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JZXN | ICU |
|---|---|---|
| Price | $1.84 | $0.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 839.1K | ★ 2.3M |
| Earning Date | 03-05-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $97,465.00 | ★ $881,000.00 |
| Revenue This Year | N/A | $691.85 |
| Revenue Next Year | N/A | $64.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1195.59 |
| 52 Week Low | $1.58 | $0.22 |
| 52 Week High | $312.80 | $3.07 |
Technical Indicators
Market Signals| Indicator | JZXN | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 32.77 |
| Support Level | $1.58 | $0.23 |
| Resistance Level | $2.09 | $0.28 |
| Average True Range (ATR) | 0.85 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 20.55 | 19.24 |
Price Performance
Historical ComparisonAbout JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.